Ignite Creation Date:
2025-12-24 @ 9:43 PM
Ignite Modification Date:
2026-04-11 @ 2:06 AM
Study NCT ID:
NCT06980532
Status:
RECRUITING
Last Update Posted:
2025-05-20
First Post:
2025-05-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer
Sponsor:
Liu Huang
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TJ-IRB202502131
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None